Containment of multi-drug resistant TB in the Pacific is critical.

Professor Warwick Britton, Head of the Mycobacterial Group

Professor Warwick Britton, Head of the Mycobacterial Group at Centenary and a Professor of Medicine at the University of Sydney, has been awarded $2.49 million towards a Centre of Research Excellence on tuberculosis control: from discovery to public health practice and policy – a collaborative program with colleagues from the University of Sydney, Woolcock Institute for Medical Research, University of Melbourne, Vietnam and Indonesia.

The grant adds to Centenary’s investment and effort in containing the spread of TB, still one of the world’s most devastating infectious diseases
and a growing threat to Australia. Drug resistant strains of tuberculosis are prevalent in Papua New Guinea, our closest neighbour.

“Where multi drug resistant TB has been around for a decade or more, and has not been treated, it is completely predictable that extensively drug resistant TB – that is, TB which is resistant to the five main classes of drugs - will occur in countries like Papua New Guinea,” Professor Britton said.

Read the complete statement from Centenary Institute here.

The full list of the NHMRC Centre of Research Excellence grants announced here by Federal Health Minister, The Hon.Tanya Plibersek